-

Seeing the light: the only light adjustable lens customizable after cataract surgery now offered at Northwell Health

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--The latest development in cataract surgery is now available at several Northwell locations including Peconic Bay Medical Center, Syosset Surgical center and Manhattan Eye, Ear, and Throat Hospital. The cutting-edge Light Adjustable Lens (LAL) enables patients and their doctor to design, trial and customize vision after cataract surgery, more often giving patients their very best possible vision without eyeglasses after surgery.

A cataract is a cloudy area in the lens of the eye that leads to a decrease in vision. Cataracts often develop slowly and can affect one or both eyes. Symptoms may include faded colors, blurry or double vision, halos around light, trouble with bright lights, and trouble seeing at night.

“RxSight’s Light Adjustable Lens allows ophthalmologists to give cataract patients even more precise visual outcomes than ever before,” said Richard Braunstein, MD, senior vice president and executive director of ophthalmology at Northwell Health. “We’re always striving to provide the best care possible for our patients, and with this new technology we are living up to that goal.”

The intraocular lens is made of a unique material that reacts to UV light, which is delivered by the Light Delivery Device, as soon as 17 days after surgery. Patients receive three to five light treatments over a period of several weeks, each lasting about 40-150 seconds, depending upon the amount of adjustment needed. The patient must wear special eyeglasses for UV protection from the time of the cataract surgery to the end of the light treatments to protect the new lens from UV light in the environment.

“Small variations in healing happen in most eyes and with the Light Adjustable Lens, we gain the ability to correct even small amounts of nearsightedness, farsightedness and astigmatism,” said Scott Sheren, MD, director of ophthalmology at Northwell Health Eye Institute at Riverhead. “This lens is amazing because you can adjust its shape and thus its power in the eye and this is done without the use of a laser or conventional surgery.”

To learn more: email Ophthalmology@northwell.edu.

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 21 hospitals, about 900 outpatient facilities and more than 12,000 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 83,000 employees – 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

Contacts

Miriam Sholder
516-427-3762
msholder@northwell.edu

Northwell Health


Release Versions

Contacts

Miriam Sholder
516-427-3762
msholder@northwell.edu

More News From Northwell Health

Groundbreaking Meeting of Minds at Northwell Health’s Quantum Biology Forum Unlocks New Understanding of Life’s Fundamental Principles

MANHASSET, N.Y.--(BUSINESS WIRE)--What if healing wasn’t just about chemistry, but about the very energy and light within our bodies? This groundbreaking question guided Northwell Health’s Quantum Biology Forum, a seminal first meeting of minds held April 13-14 at United Therapeutics headquarters in Silver Spring, Maryland. Supported by Martine Rothblatt, PhD, CEO of United Therapeutics, and Northwell’s Lance B. Becker, MD, this unique event brought together over 120 pioneering scientists, indu...

Feinstein Institutes 2026 Ross Prize awarded to Drs. Michel Sadelain and Carl H. June

MANHASSET, N.Y.--(BUSINESS WIRE)--The Feinstein Institutes for Medical Research has selected Carl H. June, MD, from the University of Pennsylvania Perelman School of Medicine, and Michel Sadelain, MD, PhD, from Columbia University, to receive the 13th annual Ross Prize in Molecular Medicine. The Prize will be presented on June 11, in conjunction with The New York Academy of Sciences (NYAS), at The Cure, 345 Park Ave. S in Manhattan. The award ceremony will be part of a half-day research symposi...

Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test

MANHASSET, N.Y.--(BUSINESS WIRE)--Endometriosis, a chronic and often debilitating condition, affects roughly 10 percent of women and adolescents of reproductive age. Characterized by endometrial-like tissue growing outside the uterus, it frequently causes severe pain, infertility and a significant reduction in quality of life – including job loss, financial burdens and trouble forming and maintaining relationships. Despite its prevalence, why do patients frequently face years, even decades, bef...
Back to Newsroom